Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
ACT with NMOSD: A targeted, telehealth-delivered mental health intervention for patients & caregivers.
Journal: Multiple sclerosis and related disorders
Published: February 21, 2025
Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 18, 2024
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.
Journal: Neurodegenerative disease management
Published: August 03, 2023
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 04, 2023
A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy.
Journal: Multiple sclerosis and related disorders
Published: March 02, 2023
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: November 28, 2022
Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment.
Journal: Scientific reports
Published: September 06, 2022
Relapses in people with multiple sclerosis treated with cladribine tablets followed for up to 5 years: a plain language summary.
Journal: Neurodegenerative disease management
Published: August 26, 2022
Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability.
Journal: Health psychology and behavioral medicine
Published: March 21, 2022
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary.
Journal: Neurodegenerative disease management
Published: January 12, 2022
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 12, 2021
Last Updated: 09/26/2026